Related Experiment Video
Updated: Feb 9, 2026

Preparing T Cell Growth Factor from Rat Splenocytes
Published on: October 31, 2007
[The expression of serum hepatocyte growth factor in OSAHS]
1Department of Respiration,Jiaxian People's Hospital,Jiaxian,467100,China.
Insights
Hepatocyte growth factor (HGF) levels in peripheral blood increase with obstructive sleep apnea-hypopnea syndrome (OSAHS) severity. Detecting HGF aids in assessing OSAHS severity and cardiovascular disease risk.
Area of Science:
- Cardiology
- Pulmonology
- Biochemistry
Background:
- Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a prevalent condition associated with cardiovascular risks.
- Hepatocyte growth factor (HGF) plays a role in tissue repair and angiogenesis.
- The clinical significance of HGF in OSAHS remains to be fully elucidated.
Purpose of the Study:
- To investigate the clinical significance of peripheral blood hepatocyte growth factor (HGF) detection in patients with OSAHS.
- To correlate HGF levels with OSAHS severity and sleep respiration parameters.
- To assess the impact of treatment on HGF levels in severe OSAHS.
Main Methods:
- Ninety-six OSAHS patients were categorized into mild, moderate, and severe groups based on polysomnography (PSG) results.
- Thirty-five healthy individuals served as the control group.
- Enzyme-linked immunosorbent assay (ELISA) was used to measure peripheral blood HGF concentrations.
Main Results:
- HGF concentrations were significantly elevated in OSAHS patients compared to controls, increasing with disease severity.
- HGF levels showed a positive correlation with apnea-hypopnea index (AHI) and a negative correlation with lowest oxygen saturation (LSaO₂).
- Comprehensive treatment in severe OSAHS patients led to significant reductions in HGF levels and AHI, alongside an increase in LSaO₂.
Conclusions:
- Peripheral blood HGF levels are elevated in OSAHS patients and correlate positively with disease severity.
- HGF serves as a potential biomarker for evaluating OSAHS severity, vascular endothelial dysfunction, and cardiovascular disease risk.
- Monitoring HGF levels may aid in assessing treatment efficacy and patient prognosis.
Abstract:
Objective:To investigate the clinical significance of detecting peripheral blood hepatocyte growth factor(HGF) in OSAHS patients.Method:Ninety-six cases of OSAHS patients in our hospital were selected as OSAHS group,and were divided into 3 subgroups according to the PSG results:mild,medium and severe. Each group included 32 cases,Thirty-five cases of healthy persons were selected as control group. ELISA method was utilized to detect the HGF level of peripheral blood. HGF concentration was measured in 32 patients with severe OSAHS after 3 months of comprehensive treatment. The relationship between serum HGF and sleep respiration events was further analyzed.Result: The HGF concentration of peripheral blood increased with the severity of OSAHS.The serum levels of HGF in the control,mild,medium and severe group were(487.75±46.74)pg/ml,(519.44±50.77)pg/ml,(753.52±58.91) pg/ml and(829.49±61.74)pg/ml,respectively. There were significant differences among groups(F=117.733,P<0.01). HGF concentration in peripheral blood of OSAHS patients was unrelated to sex,age,and BMI(P>0.05),and positively correlated with AHI,negatively correlated with LSaO₂(P<0.01). After comprehensive treatment,the serum HGF concentration and AHI in severe OSAHS group were significantly decreased,while LSaO₂ was significantly increased.Conclusion:The level of HGF was increased in OSAHS patients and was positively correlated with the severity of OSAHS. Determining the level of HGF in peripheral blood is important for evaluating the severity of OSAHS and the degree of vascular endothelial dysfunction,and assessing the risk of cardiovascular disease.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity
Cell Specific Gene Expression
Transcription Factors

